Patents by Inventor Manjinder Gill

Manjinder Gill has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds and Compositions for Use in the Prevention and Treatment of Disorders of Fat Metabolism and Obesity
    Publication number: 20100048545
    Abstract: The invention relates to 4-hydroxyisoleucine, isomers, analogs, lactones, salts, and prodrugs thereof, to processes for their preparation, and to pharmaceutical compositions comprising the same. More particularly, the invention relates to the use of those compounds in the prevention and treatment of disorders of fat metabolism and related syndromes. The invention further relates to the use of those compounds in the prevention and treatment of obesity and related syndromes including, but not limited to, the cosmetic treatment of a mammal in order to effect a cosmetically beneficial loss of body weight, and more particularly loss of body fat.
    Type: Application
    Filed: March 22, 2007
    Publication date: February 25, 2010
    Applicant: INNODIA INC.
    Inventors: Lucie Jette, Patricia Mcnicol, Manjinder Gill, André Marette
  • Analogs of 4-hydroxyisoleucine and uses thereof
    Publication number: 20060199853
    Abstract: The invention relates to analogs of 4-hydroxyisoleucine, and to lactones, pharmaceutically acceptable salts, and prodrugs thereof, to processes for their preparation, and to pharmaceutical compositions comprising the same. The analogs of the invention stimulate both glucose uptake and insulin secretion, and may thus be useful for the prevention and treatment of disorders of carbohydrate or lipid metabolism, including diabetes mellitus (type 1 and type 2 diabetes), pre-diabetes, and Metabolic Syndrome.
    Type: Application
    Filed: February 17, 2006
    Publication date: September 7, 2006
    Inventors: Charles Mioskowski, Sandra Marin, Martine Maruani, Manjinder Gill
  • Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis
    Patent number: RE46558
    Abstract: Described herein are compositions and methods for preventing and/or treating diseases involving aberrant angiogenesis employing one or more benzo[c]chromen-6-one derivatives.
    Type: Grant
    Filed: July 1, 2015
    Date of Patent: September 26, 2017
    Assignee: PALOMA PHARMACEUTICALS, INC.
    Inventors: David I. Sherris, Manjinder Gill, Fupeng Ma, Sanjivanjit Kaur Bhal, Robert Dunn-Dufault, Miklos Feher, Peter Redden, Jonathan Schmidt